The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $40.80

Today's change-1.76 -4.14%
Updated June 24 4:06 PM EDT. Delayed by at least 15 minutes.
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $40.80

Today's change-1.76 -4.14%
Updated June 24 4:06 PM EDT. Delayed by at least 15 minutes.

GlaxoSmithKline PLC crosses below 125-day moving average

GlaxoSmithKline PLC closed sharply lower Friday, dropping (U.S.)$1.76 or 4.14% to (U.S.)$40.80 and crossing below its 125-day moving average. Over the last five days, shares have gained 1.17%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 2.49% during the last year.

Key company metrics

  • Open(U.S.) $40.51
  • Previous close(U.S.) $42.56
  • High(U.S.) $41.77
  • Low(U.S.) $40.48
  • Bid / Ask-- / --
  • YTD % change+1.12%
  • Volume9,547,090
  • Average volume (10-day)4,959,273
  • Average volume (1-month)3,222,125
  • Average volume (3-month)3,392,148
  • 52-week range(U.S.) $37.24 to (U.S.) $45.49
  • Beta0.80
  • Trailing P/E205.79×
  • P/E 1 year forward18.04×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.34
  • Dividend yield5.73%
  • Trailing EPS(U.S.) $0.20
Updated June 24 4:06 PM EDT. Delayed by at least 15 minutes.
S&P TSX1.69%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue6,2866,1275,8885,622
Total other revenue--------
Total revenue6,2866,1275,8885,622
Gross profit4,0824,0613,9933,745
Total cost of revenue2,2042,0661,8951,877
Total operating expense6,5395,1045,552-4,437
Selling / general / administrative2,1221,9142,1411,951
Research & development846730731789
Depreciation / amortization109913
Interest expense (income), net operating--------
Unusual expense (income)910282838-8,990
Other operating expenses, total447103-62-77
Operating income-2531,02333610,059
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-4168671529,923
Income after tax-4286471158,038
Income tax, total12220371,885
Net income-3545381498,089
Total adjustments to net income--------
Net income before extra. items-3545381498,089
Minority interest74-1093451
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-3545381498,089
Inc. avail. to common incl. extra. items-3545381498,089
Diluted net income-3545381498,089
Dilution adjustment00----
Diluted weighted average shares4,8374,8774,8744,820
Diluted EPS excluding extraordinary itemsvalue per share-0.070.110.031.68
Dividends per sharevalue per share0.230.190.190.19
Diluted normalized EPSvalue per share0.050.150.160.17